Brain metastases from colorectal cancer – a retrospective dual center study - Top-Institutions - MDSpire

Brain metastases from colorectal cancer – a retrospective dual center study

  • By

  • S. Müller

  • A. Hendricks

  • K. Uttinger

  • M. Kostatin

  • M. Brüggemann

  • M. Schrader

  • B. Polat

  • S. Flemming

  • J. F. Lock

  • C.-T. Germer

  • A. Wiegering

  • U. Pession

  • March 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Colorectal Cancer
    • Cancer Metastasis

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Colorectal Cancer
    • Radiation Oncology

  • #3

    Dana-Farber Cancer Institute / Brigham and Women’s Hospital
    Dana-Farber Cancer Institute / Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Neuro-oncology
    • Gastrointestinal Oncology
    • Translational Cancer Research

  • #4

    Comprehensive Cancer Center Mainfranken / University Hospital Frankfurt
    Comprehensive Cancer Center Mainfranken / University Hospital Frankfurt

    Wuerzburg / Frankfurt, Germany

    Key Differentiators

    • Colorectal Cancer
    • Neuro-oncology
    • Clinical Oncology

Original Source(s)

Brain metastases from colorectal cancer – a retrospective dual center study

  • by S. Müller, A. Hendricks, K. Uttinger, M. Kostatin, M. Brüggemann, M. Schrader, B. Polat, S. Flemming, J. F. Lock, C.-T. Germer, A. Wiegering, U. Pession

  • March 24, 2026

Related Content

Editorial: Insights into gastrointestinal cancer metastasis from preclinical models

Peripheral blood monocytes could be associated with brain metastasis and affect patient prognosis in breast cancer: a retrospective study

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities